The Abu Dhabi Investment Office (ADIO) has announced its support for Samvardhana Motherson International 's manufacturing hub in Abu Dhabi, further strengthening the emirate's position as a global centre for advanced manufacturing and automotive supply chains. The development was formally communicated via a press release dated May 06, 2026, filed with Indian stock exchanges by Samvardhana Motherson International's Company Secretary, Alok Goel.

Strategic Partnership Overview

The partnership between ADIO and Samvardhana Motherson International centres on the development of a large-scale integrated manufacturing facility designed to produce a range of automotive components for Motherson's global operations as well as third-party OEM customers. The key parameters of this initiative are outlined below:

Facility Details and Development Progress

Located within Khalifa Economic Zones Abu Dhabi (KEZAD), the facility is being developed in phases on a single approximately 87,652 square metre land plot, with construction already underway. Once fully operational, it will serve as a regional manufacturing and export base, leveraging Abu Dhabi's logistics infrastructure — including connectivity through AD Ports Group — to enable efficient access to regional and global markets and strengthen integration across supply chains. The project is expected to create more than 1,000 jobs across technical, engineering, manufacturing, and corporate functions, supporting Emiratization and enabling greater participation of national talent, while contributing to knowledge transfer and capability building in advanced industrial sectors.

Broader Strategic Significance

The partnership reflects ADIO's continued focus on enabling advanced manufacturing and strengthening high-value supply chains across priority industrial sectors, reinforcing Abu Dhabi's competitiveness as a regional and global manufacturing hub. It is expected to contribute to expanding non-oil exports, strengthening local supply chains, and advancing industrial capabilities in the emirate. Samvardhana Motherson International had previously informed stock exchanges about this manufacturing hub in the UAE as part of its performance presentation for the quarter and financial year ended March 31, 2025, underscoring the project's strategic importance to the company's global manufacturing footprint.

Samvardhana Motherson International Limited's Nomination and Remuneration Committee (NRC) convened on May 04, 2026, and approved the grant of Employee Stock Options (ESOPs) to eligible employees under the "Samvardhana Motherson International Limited – Employee Stock Option Scheme 2025" (ESOP Scheme 2025). The committee meeting commenced at 1540 Hours (IST) and concluded at 1610 Hours (IST). This grant follows earlier disclosures dated June 19, 2025 and August 23, 2025, in which the Board of Directors and Shareholders of the Company had respectively approved the formulation, adoption, and implementation of the ESOP Scheme 2025. The disclosure has been made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Details of the ESOP Grant

The NRC has granted a total of 23,211,370 (Twenty Three Million Two Hundred Eleven Thousand Three Hundred and Seventy) Employee Stock Options to eligible employees. Each option, upon exercise, entitles the holder to one fully paid-up equity share of the Company with a face value of Re. 1/- (Rupee One only). The following table summarises the key parameters of this grant:

Scheme Structure and Significant Terms

The ESOP Scheme 2025 is administered by the Motherson ESOP Trust, to the extent that aspects of such administration are delegated by the Committee in accordance with applicable laws. The scheme is overseen by the Nomination and Remuneration Committee, which handles all related responsibilities, including any powers or duties delegated by the Board. Key structural features of the scheme include:

• The scheme is applicable to the Company (and any successor), its employees, as well as group companies and subsidiary companies in India or abroad, and their eligible employees or eligible directors.
• The specific employees to whom options are granted, along with their eligibility criteria, are determined by the Committee upon recommendation of the management.
• Options granted shall vest not earlier than a minimum vesting period of one (1) year and not later than a maximum vesting period of five (5) years from the date of grant.
• The exercise period for vested options shall be a maximum of 3 (Three) years commencing from the date of each vesting, or such shorter period as may be prescribed by the Committee.
• Shares arising out of the exercise of vested options shall not be subject to any lock-in from the date of transfer of such shares under the ESOP Scheme 2025.
• Employees exercising options are also liable to pay the Company an amount equivalent to the perquisite tax payable on exercise, in accordance with the Income Tax Act and other applicable laws at the relevant time.

Regulatory Compliance

The ESOP Scheme 2025 is in compliance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The disclosure was made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, read with SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026. Parameters such as options vested, options exercised, money realised by exercise, total shares arising from exercise, options lapsed, variation of terms, subsequent changes or cancellations, and diluted earnings per share are not applicable at this stage, as the current disclosure pertains solely to the grant of options under the ESOP Scheme 2025.